EcoDrugPlus

Adrenoceptor Alpha 2a

Ensembl ID : ENSMPUG00000002055
Gene Symbol: ADRA2A
2 Cross references
230 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSMPUG00000018642
Gene Symbol: ADRA2B
2 Cross references
219 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSMPUG00000014292
Gene Symbol: ADRB2
2 Cross references
263 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSMPUG00000009926
Gene Symbol: ADRB3
1 Cross references
215 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSMPUG00000010140
Gene Symbol: AGER
2 Cross references
169 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSMPUG00000009642
Gene Symbol: ADH5
2 Cross references
401 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSMPUG00000004341
Gene Symbol: AKR1B1
2 Cross references
427 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSMPUG00000012223
Gene Symbol: GAA
2 Cross references
234 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSMPUG00000007554
Gene Symbol: AOC1
4 Cross references
230 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSMPUG00000013103
Gene Symbol: APCS
2 Cross references
440 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSMPUG00000001005
Gene Symbol: APP
2 Cross references
276 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSMPUG00000010521
Gene Symbol: AR
2 Cross references
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).